Abstract
Ethylenediaminetetraacetic acid, EDTA, a chelating agent with a high stability constant for lead, is commonly used for the diagnosis and treatment of pad poisoningl,2; but EDTA has also a very high stability constant for zinc and is therefore expected to bind and remove this essential trace element. In the present study the zinc loss during the use of conventional doses of EDTA for lead poisoning was determined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
S. P. Bessman and E. C. Layne, Jr., A rapid procedure for the determination of lead in blood or urine in the presence of organic chelating agents, J. Lab. Clin. Med. 45: 159 (1955).
J. J. Chisolm, Jr., The use of chelating agents in the treatment of acute and chronic lead intoxication in childhood, J. Pediatr. 73: 1 (1968).
S. Chaberek and A. E. Martell, “Organic Sequestering Agents,” J. Wiley, New York (1959).
J. B. Willis, Determination of lead and other heavy metals in urine by atomic absorption spectroscopy, Analyt. Chem. 34: 614 (1962).
H. Spencer, V. Vankinscott, I. Lewin, and D. Laszlo, Removal of calcium in man by ethylenediaminetetraacetic acid: A metabolic study, J. Clin. Invest. 31: 1023 (1952).
H. Spencer, The use of chelating agents in the study of mineral metabolism in man, in: “Metal-Binding in Medicine,” M. J. Steven and L. A. Johnson, eds., J. B. Lippincott, Philadelphia, p 104 (1960).
J. F. Holland, E. Danielson, and A. Sahagian-Edwards, Use of ethylene-diamine tetraacetic acid in hypercalcemic patients, Proc. Soc. Exp. Biol. Med. 84: 359 (1953).
H. Spencer, J. Greenberg, E. Berger, M. Perrone, and D. Laszlo, Studies of the effect of ethylenediaminetetraacetic acid in hypercalcemia, J. Lab. Clin. Med. 47: 29 (1956).
H. M. Perry, Jr. and E. F. Perry, Normal concentrations of some trace metals in human urine: Changes produced by ethylenediaminetetraacetate. J. Clin. Invest. 38: 1452 (1959).
H. M. Perry, Jr. and H. A. Schroeder, Lesions resembling vitamin B complex deficiency and urinary loss of zinc produced by ethylenediaminetetraacetate. Am. J. Med. 22: 168 (1957).
J. T. McCall, K. G. McLennan, N. P. Goldstein, et al., Copper and zinc homeostasis during chelating therapy, in: “Trace Substances in Environmental Health-II,” D. D. Hemphill, ed., University of Missouri (publ), Columbia, MO, p 127 (1968).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this chapter
Cite this chapter
Spencer, H., Agrawal, S.K., Sontag, S.J., Osis, D. (1988). Changes in Zinc Metabolism During the Use of EDTA. In: Hurley, L.S., Keen, C.L., Lönnerdal, B., Rucker, R.B. (eds) Trace Elements in Man and Animals 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0723-5_26
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0723-5_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8050-7
Online ISBN: 978-1-4613-0723-5
eBook Packages: Springer Book Archive